14
Views
0
CrossRef citations to date
0
Altmetric
Original Paper

Candida albicans PLD1 activity is required for full virulence

, , , , &
Pages 439-447 | Received 14 Feb 2003, Accepted 05 Aug 2003, Published online: 09 Jul 2009

References

  • Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 1995; 155: 1177–1184.
  • Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22\(Suppl. 2): S89—S94.
  • Wingard JR. The use of fluconazole prophylaxis in patients with chemotherapy-induced neutropenia. Leuk Lymphoma 1992; 8: 353–359.
  • Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African Amer-ican women: results of a random digit dialing survey. J Womens Health 1998; 7: 1167–1174.
  • Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C albicans mutants are avirulent. Cell 1997; 90: 939–949.
  • Rodrigues AG, Mardh PA, Pina-Vaz C, Martinez-de-Oliveira J, Fonseca AF. Germ tube formation changes surface hydrophobi-city of Candida cells. Infect Dis Obstet Gynecol 1999; 7: 222–226.
  • Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63: 1993–1998.
  • Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996; 7: 55–69.
  • Leberer E, Ziegelbauer K, Schmidt A, et al. Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p. Curr Biol 1997; 7: 539–546.
  • McLain N, Dolan JW. Phospholipase D activity is required for dimorphic transition in Candida albicans. Microbiology 1997; 143: 3521–3526.
  • Hube B, Hess D, Baker CA, Schaller M, Schafer W, Dolan JW. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology 2001; 147: 861–867.
  • Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by com-plementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 1984; 198: 179–182.
  • Vazquez-Torres A, Jones-Carson J, Wagner RD, Warner T, Balish E. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect Immun 1999; 67: 670–674.
  • Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics 1993; 134: 717–728.
  • Liu H, Kohler J, Fink GR. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 1994; 266: 1723–1726.
  • Stoldt VR, Sonneborn A, Leuker CE, Ernst JF. Efglp, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 1997; 16: 1982–1991.
  • Sherman F. Getting started with yeast. Methods Enzymol 1991; 194: 3–21.
  • Wang B, Biron C, She J, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci USA 1994; 91: 9402–9406.
  • Cantorna MT, Balish E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 1990; 58: 1093–1100.
  • Shaw J, Grund V, Durling L, Crane D, Caldwell HD. Dendritic cells pulsed with a recombinant chlamydial major outer mem-brane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun 2002; 70: 1097–1105.
  • Schaller M, Schafer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol 1998; 29: 605–615.
  • Zupi G, Marangolo M, Arancia G, Greco C, Laudonio N, Iosi F, et al . Modulation of the cytotoxic effect of 5-fluorouracil by Nmethylformamide on a human colon carcinoma cell line. Cancer Res 1988; 48: 6193–6200.
  • Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 1976; 17: 62–70.
  • Schaller M, Hube B, Ollert MW, et al . In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol 1999; 112: 383–386.
  • Schaller M, Schackert C, Korting HC, Januschke E, Hube B. Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol 2000; 114: 712–717.
  • Ernst JF. Transcription factors in Candida albicans -environmental control of morphogenesis. Microbiology 2000; 146: 1763–1774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.